Hospital News
Return to Heart Transplant Surgery Overview
More on Heart Transplant Surgery
- First Heart Patients Implanted With Next-Generation Mechanical Heart Pump
- NEJM Study Finds Drug-Eluting Stents More Effective Than Bare-Metal Stents in Heart Attack Patients
- Potential Lung Disease Biomarkers Yield Clues to COX-2 Inhibitor Side Effects
- Unique Cardiac Training Gives NewYork-Presbyterian/Columbia Doctor Ability to Treat Heart Patients With Hybrid Approach
- Reducing the Damage of a Heart Attack
- Presence of Gum Disease May Help Dentists and Physicians Identify Those at Increased Risk for Cardiovascular Disease
- First Trial of Gene Therapy for Advanced Heart Failure Shows Promising Results
- Gender Differences and Heart Disease
- FDA Approves HeartMate II Mechanical Heart Pump for Heart-Failure Patients Waiting for Organ Transplantation
- JAMA Article Looks at Data-Sharing in Clinical Trials for Heart Disease
- Physician-Scientist Urges Improved Drug Regulation to Ensure Safety of Non-Heart Drugs
- Columbia Scientists Study Advantages of Using Web to Tailor Medical Information to Patients
- New Intravascular Radiation Procedures Reduce Renarrowing of Coronary Arteries
- A NYC First: Patient Participates in Stem Cell Clinical Trial to Repair Heart Damaged by Severe Coronary Artery Disease
- For High-Blood-Pressure Patients, Preventing or Reducing Enlarged Heart Decreases Risk of Heart Failure
- Morgan Stanley Children's Hospital Performs Transcatheter Pulmonary Valve Replacement
- NewYork-Presbyterian/Weill Cornell Physician-Scientists Present Findings at American Heart Association's Annual Conference
- Columbia University Mailman School of Public Health Receives $23 Million From NHLBI to Lead Network Evaluating Novel Interventions in Cardiac Surgery
- Potential for Adult Stem Cells to Repair Hearts Damaged by Severe Coronary Artery Disease Investigated in Ongoing Study
- Health Effects of Secondhand Smoke Studied in First-of-Its-Kind Series of Clinical Studies
- Accuracy of Gene Expression Test for Heart Transplant Patients Confirmed by Independent Clinical Data
- NYC First: NewYork-Presbyterian/Columbia Cardiologists Implant Novel Stroke-Prevention Device for Heart Patients with Atrial Fibrillation
- Keeping the Beat: NewYork-Presbyterian Offers Heart Patients New Combination Defibrillator/Pacemakers
- Diabetics Benefit Less from Anti-Hypertensive Treatment to Reduce Enlarged Heart
- Larger Waistline Is Linked to Increased Risk for Heart Disease in Women
- NewYork-Presbyterian/Columbia Sets U.S. Record for Number of Heart Transplants in One Year
- Electrocardiogram Helps Predict Risk for Congestive Heart Failure in Hypertensive Patients
- Gene Test Detects Heart Transplant Rejection
- Computerized Electrocardiogram Rhythm Errors Common, NewYork-Presbyterian/Weill Cornell Study Finds
- Heart Health Inspiration & Strategies for the Whole Family
- Columbia Research Suggests Need to Rethink Causes of Heart Failure
- New Methodology Gives Weill Cornell Team Insights into Psychological Value of Cardiac Stress Testing
- Columbia University Medical Center Study Shows Stress Test Saves Lives of Patients With Chest Pain
- New Treatment for Enlarged Heart Effective, NewYork Weill Cornell Study Shows
- Reducing Enlarged Heart Muscle Cuts Patients' Cardiac Risk, Independent of Lowered Blood Pressure, NewYork-Presbyterian/Weill Cornell Researchers Report
- NewYork-Presbyterian Hospital and Columbia University Medical Center Physician-Scientists Present Clinical Research at American Heart Association's Annual Conference
- Columbia University Medical Center Instrumental in Clinical Research Leading to Medicare and Medicaid Approval To Cover Heart Pump
- New Laser Technology Offers Promise for Heart Disease Patients
- Do Heart Disease and Cancer Have a Common Genetic Link?
- Research Shows Cholesterol-Lowering Drug Lovastatin Reduces Risk of Heart Attack in Healthy Adults
- Lovastatin Treatment Reduces Events in Patients at Varying Degrees of Coronary Risk and Reduces Need for Invasive Procedures
- New Treatment May Prolong Life for Heart Transplant Patients
- "Bad" Cholesterol May Not Be the Best Predictor of Heart Disease Risk in Generally Healthy Individuals
- Lupus Patients at Increased Risk for Atherosclerosis, Weill Cornell Study Finds
- Weill Cornell Dean and Cardiovascular Expert Makes "Top Ten" Texas List
- Genetic Medicine Program at Weill Cornell Receives Major Boost from The Starr Foundation
- Weill Cornell Researchers Identify a Likely Genetic Cause of Atherosclerosis
- Left Ventricular Assist Devices May Improve Heart Function and Lead to Search for New Therapies To Obviate Need for Transplants
- Dean Antonio M. Gotto, Jr., Elected Fellow of American Academy of Arts and Sciences
- Low-Dose, Over-the-Counter Statins May Be Safe, Effective Aid in Preventing Heart Disease for Americans at Moderate Risk, Says Weill Cornell Dean
- Weill Cornell Physician-Scientists Win 2 Top Awards at American Heart Association Meeting
- Weill Cornell Scientists Reveal Action of a Histamine Receptor That May Lead to New Therapies for Heart Attacks
- First Robot-Assisted Coronary Artery Bypass Surgery in the U.S. Performed at NewYork-Presbyterian Hospital
- Hollywood Comes Knocking: Dr. Mehmet Oz of NewYork-Presbyterian Hospital is Medical Expert for Denzel Washington Film John Q
- 9/11 Lifestyle Changes May Increase Cardiovascular Risk
- FDA Approves Implanted Heart Pumps That Lengthen and Improve Lives of Terminally Ill Heart Failure Patients
- Columbia University Medical Center Releases Preliminary Results of Robotic Open-Heart Surgery Study
- Weill Cornell Receives $7.6 Million Federal Grant for Clinical Trials on New Ways To Change Behavior in Patients With Cardiopulmonary Disease
- Americans Encouraged to Make Many Lifestyle Changes, Not Just One, to Reduce Cardiovascular Risk
- Researcher Predicts Paradigm Shift in Heart Disease Treatment
- NewYork-Presbyterian/Columbia Announces State-of-the-Art, Vivian and Seymour Milstein Family Heart Center in Washington Heights
Research and Clinical Trials
Return to Heart Transplant Surgery Overview
More on Heart Transplant Surgery
Clinical Services
Return to Heart Transplant Surgery Overview
More on Heart Transplant Surgery
- Advanced Diagnostics
- Alcohol Septal Ablation
- Angiograms
- Angioplasty and Stenting
- Arrhythmia Control
- Artificial Heart Devices: LVAD
- Cardiac Electrophysiologic Studies
- Cardiac Magnetic Resonance Imaging (MRI)
- Cardiac Rehabilitation
- Cardiology
- Cardiothoracic Surgery
- Catheter Ablation for Cardiac Arrhythmias
- Coronary Artery Bypass Surgery (Grafting)
- Echocardiograms
- Electrocardiograms (ECGs), Stress Tests, Holter Monitor and Event/Loop Recorders
- Heart Valve Repair and Replacement
- Implantable Converter Defibrillators and Biventricular Pacing
- Intravascular / Intracoronary and Intracardiac Ultrasound
- Nuclear Imaging For Heart Disease (PET scans, MUGA scans)
- Off-pump Surgery
- Pacemakers
- Pediatric Heart Surgery
- Preventive Cardiology
- Preventive Medicine and Nutrition
- Robotic Heart Surgery
- Surgery for Adult Congenital Heart Disease
- Tilt Testing
- Transmyocardial Revascularization
- Treatment of Peripheral Arterial Disease
- Treatments for Heart Valve Disease
Cardiothoracic Surgery
Heart Transplant Surgery
Patients with end-stage heart failure who do not respond to medical treatment may be candidates for heart transplants. In heart transplant surgery, a patient's diseased heart is removed and replaced with a healthy, donated human heart. NewYork-Presbyterian Hospital has a distinguished history of advancing "standards of care" and the survival rates of our patients by using innovative surgical techniques, applying our basic scientific research in immunosuppression to the clinical setting, and inventing and perfecting life-sustaining cardiac assist devices that prolong life while waiting for organ availability. Surgeons at NewYork-Presbyterian have already performed more heart transplants – over 1700 – since 1977.
Every year, heart transplant surgery remains limited to the most severe cases. This is due, in part, to a shortage of donor hearts, which must pass through a stringent screening process. Moreover, the need for donated hearts goes beyond those on the transplant waiting list. There are many patients who — because of complicating health issues or age restrictions — are not eligible to be included on the transplant waiting list, yet are in need of a transplant.
In an attempt to address these problems, the heart transplant team at NewYork-Presbyterian Hospital recently launched the Alternative Heart Transplant Program, which expands the usual criteria by which donor hearts are accepted. If, after careful assessment by our transplant team, the donor heart’s function is found to be acceptable, the program tries to match the heart to a patient who would otherwise not be eligible for transplant.
Contact
- Cardiothoracic Surgery, NewYork-Presbyterian/Weill Cornell
-
Directions
(212) 746-5151
- Cardiothoracic Surgery, NewYork-Presbyterian/Columbia
-
Directions
(212) 305-8312
